EW Net Income Growth
Edwards Lifesciences · Net Income Growth
EW Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-75.75%period ending
EW TTM Net Income YoY % (98.62% → -75.75%)
Year-over-year change
High-resolution chart · PNG
EW net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -75.7517% | |
| -73.8446% | |
| -74.3504% | |
| -67.1703% | |
| 181.8417% | |
| 195.5227% | |
| 197.49% | |
| 190.4675% | |
| 5.8222% | |
| -5.0376% | |
| -7.852% | |
| -1.9125% | |
| -4.528% | |
| -3.2304% | |
| 1.2507% | |
| -1.2523% | |
| -0.4787% | |
| 80.7873% | |
| 82.548% | |
| 86.0345% | |
| 96.6649% | |
| -23.1811% | |
| -21.3487% | |
| 2.6367% | |
| 2.5797% | |
| 44.7537% | |
| 44.9598% | |
| 3.0364% | |
| 4.2872% | |
| 27.8697% | |
| 16.0907% | |
| 0.8055% | |
| -2.9461% | |
| -8.8625% | |
| 9.2362% | |
| 35.019% | |
| 35.5413% | |
| 27.6385% | |
| 15.0738% | |
| 19.0548% | |
| 20.1182% | |
| -41.1462% | |
| -38.9841% | |
| -40.414% | |
| -42.1108% | |
| 185.4997% | |
| 108.0811% | |
| 91.9773% | |
| 91.1698% | |
| -17.6882% | |
| 32.9468% | |
| 52.7526% | |
| 60.5412% | |
| 56.3682% | |
| 23.8699% | |
| 11.2416% | |
| 5.4514% | |
| 1.5798% | |
| 8.578% | |
| 18.7251% | |
| 3.7561% | |
| 8.2755% | |
| -4.845% | |
| -8.561% | |
| 26.4246% | |
| 26.3435% | |
| 77.7347% | |
| 106.0038% | |
| 74.1245% | |
| 74.6939% | |
| 14.0708% | |
| -9.5844% | |
| -11.8353% | |
| -16.8081% | |
| -13.4763% | |
| -20.6061% | |
| 0.258% | |
| 25.186% | |
| 64.691% | |
| 122.973% | |
| 39.4484% | |
| -0.9474% | |
| 4,564.7059% | |
| 1,356.6038% | |
| 1,126.4706% | |
| 3,858.3333% | |
| -97.8481% | |
| -106.4792% | |
| -82.9574% | |
| -95.1417% | |
| 41.8312% | |
| 61.9802% | |
| -51.5777% | |
| 1,366.6667% | |
| 564.1667% | |
| 1,464.8649% | |
| 697.1014% | |
| 98.5399% | |
| 95.4338% | |
| 98.6173% |